Clinical Trials Browser

INDUSTRY × Breast Neoplasms × sargramostim × Clear all

NCT05163223 2024-06-17

Cornerstone001

Phase 2 Terminated

Breast Neoplasms

NCT02297698 2023-12-12

HER3+

Phase 2 Completed

100 enrolled 11 charts

Breast Neoplasms

NCT01479244 2017-02-27

PRESENT

Phase 3 Completed

Breast Neoplasms